Tango Therapeutics
TNGX----
Tango Therapeutics (TNGX)
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Tango Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$44.3361.51%
Forecast & RatingStrong buy
13analysts
- Strong buy84.62%
- Buy7.69%
- Hold7.69%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jul 19 at 07:15 AM
Mizuho Securities Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)
- benzinga_article · Jul 15 at 05:59 AM
This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
- Global Report · Jul 14 at 06:47 AM
The Great Uncoupling: Defense Tech Thrives While Consumer Stocks Scramble
- Tip Ranks · Jul 9 at 04:54 AM
2 Monster Growth Stocks Analysts Think Can Reach New Highs
- PUBT · Jul 2 at 06:24 PM
Tango Therapeutics President, R&D Crystal Adam disposes of common shares worth $798,704
- PUBT · Jun 23 at 05:04 PM
Tango Therapeutics director Robert Azelby files initial beneficial ownership statement
